Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henry G Bone

Showing results (21-30 of 55) with videos related to

Pageof 6
Sort By:
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 6, 2003
Identification of a novel tandem duplication in exon 1 of the TNFRSF11A gene in two unrelated patients with familial expansile osteolysisTeresa L Johnson-Pais, Frederick R Singer, Henry G Bone, et al.
Bone|November 4, 2006
Disassociation of bone resorption and formation by GLP-2: a 14-day study in healthy postmenopausal womenDennis B Henriksen, Peter Alexandersen, Bolette Hartmann, et al.
Bone|July 28, 2009
Four-month treatment with GLP-2 significantly increases hip BMD: a randomized, placebo-controlled, dose-ranging study in postmenopausal women with low BMDDennis B Henriksen, Peter Alexandersen, Bolette Hartmann, et al.
The Journal of Clinical Endocrinology and Metabolism|November 20, 2014
Paget's disease of bone: an endocrine society clinical practice guidelineFrederick R Singer, Henry G Bone, David J Hosking, et al.
Bone|March 3, 2007
A cross-sectional study of bone turnover markers in healthy premenopausal womenAnne E de Papp, Henry G Bone, Michael P Caulfield, et al.
The Journal of Clinical Endocrinology and Metabolism|April 7, 2015
Response to the letter by Asik M., et alFrederick R Singer, Henry G Bone, David J Hosking, et al.
The Journal of Clinical Endocrinology and Metabolism|August 30, 2007
Effects of atorvastatin on bone in postmenopausal women with dyslipidemia: a double-blind, placebo-controlled, dose-ranging trialHenry G Bone, Douglas P Kiel, Robert S Lindsay, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 15, 2009
Effects of denosumab on bone mineral density and bone turnover in postmenopausal women transitioning from alendronate therapyDavid L Kendler, Christian Roux, Claude Laurent Benhamou, et al.
The Journal of Clinical Endocrinology and Metabolism|February 4, 2011
Effects of denosumab treatment and discontinuation on bone mineral density and bone turnover markers in postmenopausal women with low bone massHenry G Bone, Michael A Bolognese, Chui Kin Yuen, et al.
Obstetrics and Gynecology|April 12, 2003
Therapeutic equivalence of alendronate 35 milligrams once weekly and 5 milligrams daily in the prevention of postmenopausal osteoporosisMarjorie M Luckey, Nigel Gilchrist, Henry G Bone, et al.
Pageof 6

Showing results (21-30 of 55) with videos related to

Sort By:
Pageof 6
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 6, 2003
Identification of a novel tandem duplication in exon 1 of the TNFRSF11A gene in two unrelated patients with familial expansile osteolysisTeresa L Johnson-Pais, Frederick R Singer, Henry G Bone, et al.
Bone|November 4, 2006
Disassociation of bone resorption and formation by GLP-2: a 14-day study in healthy postmenopausal womenDennis B Henriksen, Peter Alexandersen, Bolette Hartmann, et al.
Bone|July 28, 2009
Four-month treatment with GLP-2 significantly increases hip BMD: a randomized, placebo-controlled, dose-ranging study in postmenopausal women with low BMDDennis B Henriksen, Peter Alexandersen, Bolette Hartmann, et al.
The Journal of Clinical Endocrinology and Metabolism|November 20, 2014
Paget's disease of bone: an endocrine society clinical practice guidelineFrederick R Singer, Henry G Bone, David J Hosking, et al.
Bone|March 3, 2007
A cross-sectional study of bone turnover markers in healthy premenopausal womenAnne E de Papp, Henry G Bone, Michael P Caulfield, et al.
The Journal of Clinical Endocrinology and Metabolism|April 7, 2015
Response to the letter by Asik M., et alFrederick R Singer, Henry G Bone, David J Hosking, et al.
The Journal of Clinical Endocrinology and Metabolism|August 30, 2007
Effects of atorvastatin on bone in postmenopausal women with dyslipidemia: a double-blind, placebo-controlled, dose-ranging trialHenry G Bone, Douglas P Kiel, Robert S Lindsay, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 15, 2009
Effects of denosumab on bone mineral density and bone turnover in postmenopausal women transitioning from alendronate therapyDavid L Kendler, Christian Roux, Claude Laurent Benhamou, et al.
The Journal of Clinical Endocrinology and Metabolism|February 4, 2011
Effects of denosumab treatment and discontinuation on bone mineral density and bone turnover markers in postmenopausal women with low bone massHenry G Bone, Michael A Bolognese, Chui Kin Yuen, et al.
Obstetrics and Gynecology|April 12, 2003
Therapeutic equivalence of alendronate 35 milligrams once weekly and 5 milligrams daily in the prevention of postmenopausal osteoporosisMarjorie M Luckey, Nigel Gilchrist, Henry G Bone, et al.
Pageof 6